Pituitary apoplexy - medical information / with case studies

martinshaji 587 views 24 slides Aug 23, 2020
Slide 1
Slide 1 of 24
Slide 1
1
Slide 2
2
Slide 3
3
Slide 4
4
Slide 5
5
Slide 6
6
Slide 7
7
Slide 8
8
Slide 9
9
Slide 10
10
Slide 11
11
Slide 12
12
Slide 13
13
Slide 14
14
Slide 15
15
Slide 16
16
Slide 17
17
Slide 18
18
Slide 19
19
Slide 20
20
Slide 21
21
Slide 22
22
Slide 23
23
Slide 24
24

About This Presentation

The word apoplexy is defined as a sudden neurologic impairment, usually due to a vascular process. Pituitary apoplexy is characterized by a sudden onset of headache, visual symptoms, altered mental status, and hormonal dysfunction due to acute hemorrhage or infarction of a pituitary gland.Pituitary ...


Slide Content

Pituitary Apoplexy ( medical information ) PRESENTED BY MARTIN SHAJI PHARM D

Introduction The word “apoplexy” comes from the Greek “ apoplexia ” meaning a seizure, in the sense of being struck down. In Greek “ plexe ” is “a stroke.” The ancients believed that someone suffering a stroke had been struck down by the gods apoplexy :a sudden neurologic impairment,‘ Love usually due to a vascular process.

•:• Pituitary apoplexy : -- sudden onset of headache- - visual symptoms(‘F&VC : optic nerve or chiasm Ocular motility: cranial nerves in cavernous sinus ) -- altered mental status -- hormonal dysfunction •:• There ¡s usually an existing pituitary adenoma present.

Pathophysiology- stems from an acute expansion of a pituitary adenoma or, less commonly, in a no adenomatous gland, from infarction or hemorrhage .- - Some postulate: gradual enlarging pituitary tumor -)compressing and distorting the hypophyseal stalk and its vascular supply4causing ischemia and subsequent necrosis -- Another theory :rapid expansion of the tumor outstrips its vascular supply-) resulting in ischemia and necrosis(doubtful?4 tumors that undergo apoplexy are slow growing

•:• Frequency : This condition results ¡n an estimated 1.5-27.7% of cases of pituitary adenoma •:• Sex: Male-to-female predominance ¡s 2:1 . •:• Age: The age range is 37-57 years.

Clinical manifestations •:• headache ¡n 95% of cases . The headache ¡s sudden .Frequently, ¡t ¡s retro orbital ¡n location and may be unilateral at onset, then becomes generalized . •:• Vomiting occurs ¡n 69% of patients and often accompanies the headache.

Clinical manifestations •:• The classic visual field defect is a bitemporal superior quadratic defect . •:• Ocular paresis (78%) results from compression of the cavernous sinus, which make cranial nerves Ill , IV, VI vulnerable to compression . diplopia may be present . Of the cranial nerves, the occulomotor nerve is involved most commonly- uniIateral dilated pupil, ptosis Less commonly, cranial nerve IV is involved

Clinical manifestations •:• Homer syndrome may develop from damage to the sympathetic fibres. •:• Involvement of the hypothalamus may alter thermal regulation . •:• Destruction of adenohypophyseal tissue may lead to endocrinologic deficiencies.

Predisposing factors •:• Predisposing factors :endocrine stimulation tests , bromocriptine treatment, head trauma, pregnancy, and pituitary irradiation . •:• Some believe :more prevalent in patients who produce excess pituitary hormones ( eg , acromegaly , Cushing syndrome ) — because the tumour is fuelled by the hormones . - Others :most pituitary tumours that undergo Love apoplexy are endocrinologically silent.

Sheehan syndrome •:• Sheehan syndrome refers to pituitary apoplexy of anon tumorous gland , presumably due to postpartum arterial spasm of arterioles supplying the anterior pituitary and its stalk. •:• In 1937, Sheehan reported 11 cases of women who died in the puerperium -- 11/11 necrosis of the anterior pituitary gland -- 9/11 severe hemorrhage at delivery . -- 2/11 no haemorrhage but were gravely ill prior to delivery .

•:• The pituitary gland hypertrophies in pregnancy. This hypertrophy combined with locally released factors. meditvascular spasm -) more susceptible to infraction from compromised blood flow .

Sheehan syndrome •:• inability to lactate (prolactin deficiency ) amenorrhea (gonadotropin deficiency ), skin depigmentation . •:• hypothyroidism hypoadrenalism diabetes insipidus (posterior pituitary involvement)

Imaging Studies •:• CT scan and MRI . MRl is the most sensitive imaging study for evaluating the pituitary gland, possibly visualizing hemorrhage not seen on CT scan . ln the first 3-5 days, hemorrhage within the sella is isointense or hypointense on TI-weighted images . On T2-weighted sequences, the blood appears hypointense .

Imaging findings •:• CT : CT(-): -acute : seller/ suprasellar mass with patchy or confluent hyperdensity,may associated with SAH -chronic: ”empty sella ”(filled with CSF)CT(+):minimal or no enhancement ( rim pattern suggestive of PA ).

Imaging findings •:• MR : Ti :early acute, enlarged gland, iso / hypointense with brain late acute/ subacute : hyperintensechronic : hypointense T2: acute : enlarged, hypointense (haemorrhagic) or hyperintense ( nonhemorrhagic ) pituitarysubacute:hyperintenseChronic:hyperintense T1+: rim enhancement

•:• 69 y/o male •:• Headache, vomiting •:• L’t ptosis, L’t EOM limitation(medial ) •:• Fever—)antibiotics , subsided after steroid usage •:• Ptosis persistent-transfer to NS for operation •:• Pathology report : pituitary adenoma cases

•:• CT(-):a sellar lesion with slight high density •:. CT(+): without obvious intra-lesion enhancement case

•:• mixed signal intensity on T1W, T2W images . Hematoma content is suspected. Mild , stud contrast enhancement.

•:• 46-year-old man,- sudden onset of severe headache- no projectile vomiting,- followed by high fever and cranial nerve palsies •:• a large heterogeneous mass, highly consistent with hemorrhagic macroadenoma

•:• Precontrast TI :a heterogeneous mass in the sella ,

•:• T2 and FLAIR :heterogeneity of signal, consistent with hemorrhage and or proteinaceous debris.

•:• Post contrast TI: no detectable enhancement . •:• The normal calibler left cavernous carotid (first image ) •:• narrowed right cavernous carotid (following 3 images w/ arrows ).

Treatment •:• Administer high-dose corticosteroids (most patients have hypopituitarism). Hydrocortisone lOOmg IV initially, then q6-8h until surgery •:• evaluate electrolytes, glucose, and pituitary hormones •:• Administer appropriate endocrinologic replacement therapy alone or combined with transsphenoidal surgicaldecompression of the tumour ,

THANK UU……